HARNIVIST

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark HARNIVIST was filed as Word mark on 01/16/2020 at the World Intellectual Property Organization.

Trademark Details Last update: October 31, 2022

Trademark form Word mark
File reference 1521090
Register number 40201915545R
Countries Australia Canada Switzerland em United Kingdom India Japan South Korea Mexico United States of America (USA)
Base trademark SG No. 40201915545R, July 17, 2019
Application date January 16, 2020
Expiration date January 16, 2030

Trademark owner

8 TEMASEK BOULEVARD,
#24-02 SUNTEC TOWER THREE
SG

Trademark representatives

Christensen O'Connor Johnson Kindness, 1201 Third Avenue, Suite 3600 US

goods and services

01 Chemical and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells; kits comprising chemical reagents and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits comprising chemical reagents and biochemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells; chemical, biochemical and biotechnological products for industrial and scientific purposes; chemical, biochemical and biotechnological products for use in research and test laboratories; chemical, biochemical and biotechnological products; reagents for the preparation or transport of biological molecules
05 Pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer and autoimmune diseases for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of cancer and autoimmune disease; pharmaceutical preparations for T-cell therapy; biological preparations for the treatment of cancer and autoimmune disease; medical preparations for therapeutic purposes; preparations for cell therapy; preparations for cancer therapies; chimeric antigen receptors (CAR) and therapeutic preparations thereof; antibodies; preparations for genetically modifying human cells for medical purposes, including viral vectors; preparations of blood extracted from humans which have been adapted for therapeutic purposes; biopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and treatment of cancer and autoimmune disease

Trademark history

Date Document number Area Entry
October 19, 2022 2022/43 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 10, 2021 2021/50 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 28, 2021 2021/44 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 21, 2021 2021/30 Gaz CA Rejection
July 19, 2021 2021/29 Gaz MX Rejection
May 13, 2021 2021/19 Gaz JP Rejection
April 27, 2021 2021/17 Gaz KR Rejection
April 26, 2021 2021/17 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 11, 2021 2021/6 Gaz CH Rejection
December 14, 2020 2020/51 Gaz IN Rejection
September 25, 2020 2020/39 Gaz AU Rejection
August 20, 2020 2020/34 Gaz GB Rejection
August 11, 2020 2020/33 Gaz EM Rejection
April 21, 2020 2020/17 Gaz US Rejection
January 16, 2020 2020/10 Gaz SG Registration

ID: 141521090